VIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharmacologic therapy (OPT) for heart failure and who meet any one of the following classifications: (1) Moderate to severe heart failure (NYHA Class III-IV) with EF d 35% and QRS duration e 120 ms; (2) Left bundle branch block (LBBB) with QRS duration e 130 ms, EF d 30%, and mild (NYHA Class II) ischemic or nonischemic heart failure or asymptomatic (NYHA Class I) ischemic heart failure.
Published November 15, 2017 · Recall initiated: October 4, 2017
Summary
FDA records medical device Class II recall Z-0079-2018, published November 15, 2017 and initiated October 4, 2017. Recalling firm: Boston Scientific Corporation; Status: Terminated; Reported quantity: 4 devices; Lot: Serial numbers 174170, 174349, 174598, and 174606. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The devices have an incorrect firmware configuration.
What to do
Voluntary: Firm initiated · Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boston Scientific Corporation
- Distributor
- The devices were distributed to medical facilities located in MN and OH. There was no foreign/government/military distribution.
- Lot
- Serial numbers 174170, 174349, 174598, and 174606.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDANaviFlex LW Pusher; Advx Panc. Stent 4/5F; Material Number (UPN): M00535030;October 21, 2026
- FDAImager II Angiographic Catheters M001314001 IMAGER II/5/ST/65/038 BX5; M001314011 IMAGER II/5/ST/100/038 BX5;September 30, 2026
- FDABoston Scientific Corporation StoneSmart Connect Console Contents: (1) Power Cord, (1) Power Adaptor, (1)DVISeptember 23, 2026
- FDALUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS US, Model NumberSeptember 9, 2026
- FDARESONATE EL ICD DR, Model D433, Sterile.November 15, 2017
- FDAMOMENTUM X4 CRT-D, Model G138, Sterile.November 15, 2017
Questions about this recall
Was VIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharmacologic therapy (OPT) for heart failure and who meet any one of the following classifications: (1) Moderate to severe heart failure (NYHA Class III-IV) with EF d 35% and QRS duration e 120 ms; (2) Left bundle branch block (LBBB) with QRS duration e 130 ms, EF d 30%, and mild (NYHA Class II) ischemic or nonischemic heart failure or asymptomatic (NYHA Class I) ischemic heart failure. recalled?
Yes. FDA published recall Z-0079-2018 on November 15, 2017. Reported hazard: The devices have an incorrect firmware configuration.
What should I do if I have this product?
Voluntary: Firm initiated · Visit